Detailed model of the aggregation event between two fractal clusters.

Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH Zurich, Hönggerberg HCI, 8093 Zurich, Switzerland.
The Journal of Physical Chemistry B (Impact Factor: 3.61). 05/2006; 110(13):6574-86. DOI:10.1021/jp056538e
Source: PubMed

ABSTRACT A model has been developed for describing the aggregation process of two fractal clusters under quiescent conditions. The model uses the approach originally proposed by Smoluchowski for the diffusion-limited aggregation of two spherical particles but accounts for the possibility of interpenetration between the fractal clusters. It is assumed that when a cluster diffuses toward a reference cluster their center-to-center distance can be smaller than the sum of their radii, and their aggregation process is modeled using a diffusion-reaction equation. The reactivity of the clusters is assumed to depend on the reactivity and number of their particles involved in the aggregation event. The model can be applied to evaluate the aggregation rate constant as a function of the prevailing operating conditions by simply changing the value of the particle stability ratio, without any a priori specification of a diffusion-limited cluster aggregation, reaction-limited cluster aggregation, or transition regime. Furthermore, the model allows one to estimate the structure properties of the formed cluster after the aggregation, based on the computed distance between the aggregating clusters in the final cluster.

0 0
  • [show abstract] [hide abstract]
    ABSTRACT: Recently reported colloidal aggregation data obtained for different monovalent salts (NaCl, NaNO(3), and NaSCN) and at high electrolyte concentrations are matched with the stochastic solutions of the master equation to obtain bond average lifetimes and bond formation probabilities. This was done for a cationic and an anionic system of similar particle size and absolute charge. Following the series Cl(-), NO(3)(-), SCN(-), the parameters obtained from the fitting procedure to the kinetic data suggest: (i) The existence of a potential of mean force (PMF) barrier and an increasing trend for it for both lattices. (ii) An increasing trend for the PMF at contact, for the cationic system, and a practically constant value for the anionic system. (iii) A decreasing trend for the depth of the secondary minimum. This complex behavior is in general supported by Monte Carlo simulations, which are implemented to obtain the PMF of a pair of colloidal particles immersed in the corresponding electrolyte solution. All these findings contrast the Derjaguin, Landau, Verwey, and Overbeek theory predictions.
    The Journal of Chemical Physics 10/2011; 135(13):134704. · 3.16 Impact Factor
  • [show abstract] [hide abstract]
    ABSTRACT: We study, using wide-angle and small-angle light scattering techniques, the stability and aggregation/gelation behaviors of denatured filamentous bovine serum albumin pre-aggregates (BSA-PAs), induced by CaCl(2). It is observed that transparent filamentous gels can be formed not only at low CaCl(2) concentrations but also at high CaCl(2) concentrations, while turbid gels are obtained at intermediate CaCl(2) concentrations. Although the filamentous gels at low CaCl(2) concentrations and the turbid gels at intermediate CaCl(2) concentrations are consistent with the literature observations, the filamentous gels at high CaCl(2) concentrations have to be explained by different mechanisms. The latter is attributed to the repulsive hydration interactions originating from increased surface dipoles generated by counterion binding. Since such surface dipole-induced hydration is very short-range and occurs mainly on charged or polar patches of proteins (thus protected from aggregation), the aggregation of the filamentous BSA-PAs at hydrophobic patches at the two ends is still possible, leading to formation of the filamentous gels.
    Physical Chemistry Chemical Physics 03/2012; 14(14):4906-16. · 3.83 Impact Factor
  • European Urology Supplements - EUR UROL SUPPL. 01/2011; 10(7):462-462.